comparative effectiveness

Research in Review

Prognostic Implications of ETS2 Expression in AML

07/25/2017

JCP Editors

Elevated expression levels of ETS2 were a strong predictor of prognosis in acute myeloid leukemia (AML) and should be used to guide treatment decisions, according to recent research published in Journal of...

...

07/25/2017

Journal of Clinical Pathways

Research in Review

Immunotherapy Diminishes Regulatory T-Cells, Improves Outcomes in AML

07/20/2017

JCP Editors

Immunotherapy after complete remission in acute myeloid leukemia (AML) is associated with decreasing levels of regulatory T-cells, which leads to favorable clinical outcomes, according to research published in Cancer...

...

07/20/2017

Journal of Clinical Pathways

Research in Review

SBRT Deemed Safe and Effective in Older Patients With Lung Cancer

07/19/2017

JCP Editors

Stereotactic body radiation therapy (SBRT) is a safe treatment for patients aged 80 years or older with early-stage lung cancer, according to a recent study published in the International Journal of Radiation...

...

07/19/2017

Journal of Clinical Pathways

Research in Review

Biomarker Screening Pathway Aids Diagnosis of Monogenic Diabetes

07/18/2017

JCP Editors

A biomarker screening pathway for monogenic diabetes is an effective and easy approach to systematically screening young-onset patients, according to results of a population-based assessment published in Diabetes...

A...

07/18/2017

Journal of Clinical Pathways

Research in Review

Triplet Combination Shows Durable Responses in Advanced Multiple Myeloma

07/17/2017

JCP Editors

Patients with heavily treated multiple myeloma showed rapid and durable responses to a novel treatment combination, according to a recent study published in Blood (July 2017;...

...

07/17/2017

Journal of Clinical Pathways

Research in Review

Prognostic Indicator Identified for Patients With DLBCL

07/14/2017

JCP Editors

Patients with diffuse large B-cell lymphoma (DLBCL) with a specific disease characteristic are expected to have poor clinical outcomes, according to research published in Leukemia (published online July 12, 2017;...

...

07/14/2017

Journal of Clinical Pathways

Research in Review

Comparing Prognostic Values of MRI or PET-CT at Multiple Myeloma Diagnosis

07/12/2017

JCP Editors

Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...

...

07/12/2017

Journal of Clinical Pathways

Research in Review

Mastectomy Not Cost-Effective for Most Patients With Ovarian Cancer

07/12/2017

JCP Editors

Risk-reducing mastectomy within five years of ovarian cancer diagnosis is not cost-effective compared with surveillance for patients with BRCA mutations, according to research published in Annals of Surgical Oncology...

...

07/12/2017

Journal of Clinical Pathways

Research in Review

Blood Test Predicts Survival Outcomes in Patients With Type of Lung Cancer

07/11/2017

JCP Editors

A blood-based proteomic test offers prognostic information and optimal second-line treatment guidance for patients with squamous cell carcinoma (SCC) of the lung, according to research published in Lung Cancer (July...

A...

07/11/2017

Journal of Clinical Pathways

Research in Review

Common Second-Line Treatment for Liver Cancer Deemed Not Cost-Effective

07/03/2017

JCP Editors

A conventional second-line treatment for hepatocellular carcinoma offers only a marginal increase in quality-adjusted life-years (QALYs) at a significantly high cost, according to an analysis published in Cancer...

A...

07/03/2017

Journal of Clinical Pathways